Currently, the 750mcg teriparatide injection formulation is accessible in AU however this access is conditional. Typically , it’s recommended for patients with severe osteoporosis who display an failure to respond adequately to, or cannot tolerate, alternative therapies. Regarding cost can fluctuate significantly depending on the supplier, insura